Why pandemic vaccine vendor Salman F Rahman faces an ACC probe | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Friday
July 11, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
FRIDAY, JULY 11, 2025
Why pandemic vaccine vendor Salman F Rahman faces an ACC probe

Corruption

TBS Report
18 March, 2025, 12:45 am
Last modified: 18 March, 2025, 05:23 pm

Related News

  • ACC files two cases against KCC's ex-mayor Khaleque, wife for illegal wealth
  • HC orders reinstatement of ACC official Sharif, who was fired after probing high-profile corruption
  • ACC sues Saad Musa Group chief over TK95cr embezzlement
  • ACC launches probe against 2 more NBR commissioners, 3 other officials
  • NCP leaders accuse ACC of demanding bribe, commission denies claim

Why pandemic vaccine vendor Salman F Rahman faces an ACC probe

Salman allegedly embezzled Tk22,000cr in Covid vaccine procurement

TBS Report
18 March, 2025, 12:45 am
Last modified: 18 March, 2025, 05:23 pm

On 8 March 2020, Bangladesh confirmed its first Covid-19 case, and the nation braced for impact. Ten days later, the first death occurred, triggering widespread panic. Dhaka, typically a vibrant city filled with traffic and activity, fell into an unsettling stillness. Streets emptied, shops closed, and livelihoods disappeared abruptly. Fear became so intense that families often refused to handle the bodies of their deceased loved ones, even for burial.

Amid this fear and paralysis, however, one individual acted decisively. While others perceived only death, he recognised an opportunity.

Salman F Rahman, vice chairman of Beximco Group and then private industry and investment adviser to ousted prime minister Sheikh Hasina, emerged as a key player in Bangladesh's vaccine procurement drive. His company Beximco Pharmaceuticals was handed an exclusive contract – without any tender or competition – to import 30 million doses of the Oxford-AstraZeneca vaccine from the Serum Institute of India.

It was a deal that raised eyebrows but nobody was there to question it.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

For every dose imported, Beximco made a clean profit of Tk77. This was after all costs – logistics, transportation, and overhead – had been accounted for.

The numbers, however, told a starker story. According to a World Health Organization (WHO) report, Bangladesh ended up paying more than Tk1,550 per dose – by far the highest price among neighbouring countries. For comparison, India paid Tk439 per dose, Nepal Tk362, and the Maldives Tk447.

For Bangladesh, the two doses needed to inoculate one person cost Tk3,178. Across the border, India vaccinated its citizens for less than a third of that amount.

When questions surfaced about this glaring disparity, the answers were evasive. The then boss of the Directorate General of Health Services, Dr Abdul Basar Mohammad Khurshid Alam, the DG, deflected responsibility.

He told reporters that it was the Ministry of Health that had negotiated the deal, and that the terms were bound by a non-disclosure agreement. The then health minister echoed the same line in parliament when MPs pressed for clarity. The price, he said, could not be disclosed.

But numbers spoke louder than any statements.

As the vaccines arrived and the nation's nerves calmed, Beximco's fortunes soared. Its pharmaceutical unit's share price shot up to Tk255 from Tk136 within 11 months of the vaccine deal. It was a windfall born in a time of national despair.

From vaccine king to ACC radar

Salman was hailed as the man who delivered hope when fear paralysed the nation. But now, he is under the scanner of the Anti-Corruption Commission (ACC).

The ACC has formally decided to launch an inquiry into allegations that a powerful syndicate, led by Salman and a handful of others, syphoned off Tk22,000 crore of public funds during the procurement of Covid-19 vaccines.

The announcement came yesterday afternoon from ACC Director General Akhtar Hossain. Briefing journalists, Akhtar said the inquiry is based on a complaint filed by Moidul Islam, an official at the Bangladesh Medical Research Council (BMRC).

Moidul said the health department in its advertisements initially said the Sinopharm vaccine cost the government $100 per dose, later a government committee approved the same at $10.

"This is how vaccine procurement was corrupted," said Moidul. 

According to the complaint, Beximco Pharmaceuticals, where Salman F Rahman serves as vice chairman, was inserted as a third-party supplier in Bangladesh's deal to procure 3 crore doses of the Oxford-AstraZeneca vaccine from India's Serum Institute. The inclusion, it is alleged, was done without justification – violating government procurement protocols and effectively inflating the price Bangladesh paid for each dose.

And the numbers are staggering.

A crime against humanity?

The complaint claims that had the government dealt directly with the Serum Institute, the savings could have secured an additional 6.8 million vaccine doses – doses that might have mattered in a country scrambling for immunity.

"Covid-19 global vaccine allocation is based on power, first mover advantage, and the ability to pay," peer-reviewed medical journal BMJ wrote in an article on 16 August 2021.

The article titled "Profiteering from vaccine inequity: a crime against humanity?" said the moral scandal, enabled by corporate and political permission of mass death, is "tantamount to a crime against humanity". 

Meanwhile, it was not the first time questions have swirled around the vaccine deal. 

Back in August 2022, then health minister Zahid Maleque revealed that the government had already spent Tk40,000 crore on vaccines and related expenses – a sum that raised eyebrows but drew no formal scrutiny. Transparency International Bangladesh then opined that the sum should not have crossed Tk18,000 crore.

ACC's Akhtar Hossain was cautious when asked about the specifics. "It is not possible to provide details on how these funds were embezzled at this moment," he said. "We will share further information after the investigation."

Alongside Salman F Rahman, several high-profile officials have been named in the complaint as part of the alleged corrupt syndicate. Among them are former health minister Zahid Maleque, health secretary Lokman Hossain, BMRC chairman Professor Modasser Ali, and Ahmed Kaikaus, the former principal secretary to the prime minister.

Blocking Bangavax

The complaint alleges that this syndicate deliberately obstructed the approval process for Bangavax, a locally developed Covid-19 vaccine by Globe Biotech. The authorities repeatedly demanded unnecessary documents and imposed trivial conditions, stalling the vaccine's progress for months.

By the time Bangavax was finally granted approval for clinical trials in July 2022, the pandemic had largely subsided – and the opportunity for meaningful contribution had passed.

"Half a dozen letters to the Prime Minister's Office yielded no results," the complaint claims. "Instead, Globe Biotech's offices were attacked, and its researchers received threats from various quarters."

Salman F Rahman, according to the complaint, had pressured Globe Biotech to share its formula and technology, offering a partnership for manufacturing and marketing through Beximco. Globe refused. And then, as the complaint suggests, they were left to endure the consequences – silently absorbing the blows from what was described as "the most powerful man in the country at the time".

Globe Biotech Chairman Md Harunur Rashid told TBS, "We even tried for the approval of the clinical trial offering 40% income to Beximco, but Salman eyed taking away the technology from us.

"Our vaccine was one of the first three WHO-enlisted ones in March 2020 and the project costing us around Tk400 crore failed due to the lack of cooperation from the then government."

For Salman F Rahman, the man who once positioned himself as a saviour in Bangladesh's darkest hour, the tables seem to be turning. As investigators dig into the Tk22,000 crore trail, a simple question lingers in the public mind: how much did salvation cost, and who really paid the price?

Top News

Salman F Rahman / Covid-19 Vaccination / ACC

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Bangladesh's delegation, led by Commerce Adviser Sk Bashir Uddin, began high-level negotiations with USTR Ambassador Jamieson Greer at 9pm Bangladesh time on Thursday (10 July). Photo: Collected from the Facebook handle of Golam Mortoza, Press Minister at the Bangladesh Embassy in the US
    No need to worry as US tariff talks ongoing: Fouzul tells biz leaders
  • Infographics: TBS
    How tender rules and a lone bidder stall a $2.5b power plant
  • Commerce Adviser Sk Bashir Uddin met USTR Ambassador Jamieson Greer at the USTR office in Washington, DC on 10 July 2025. Photo: CA Press Wing
    35% tariff: Commerce adviser meets US trade representative in Washington

MOST VIEWED

  • Graphics: TBS
    BB raises startup fund limit, drops upper age barrier
  • Workers pack undergarments at the packing section of a garment factory in Ashulia, on the outskirts of Dhaka, Bangladesh, April 19, 2025. Photo: REUTERS/Fatima Tuj Johora
    After US tariffs, jobs hang by a thread in Bangladesh's garments sector
  • Photo: Mohammad Minhaj Uddin/TBS
    SSC, equivalent results: Pass rate drops to 68.45%, GPA-5 also declines
  • File photo of containers at Chattogram port/TBS
    US buyers push Bangladeshi exporters to share extra tariff costs
  • Govt vehicle purchase, foreign trip, new building construction banned: Finance ministry
    Govt vehicle purchase, foreign trip, new building construction banned: Finance ministry
  • Students sit for SSC exam at Motijheel Girls' High School on 10 April 2025. Photo: Mehedi Hasan/TBS
    SSC exam results out: Here's how you can check online and via SMS

Related News

  • ACC files two cases against KCC's ex-mayor Khaleque, wife for illegal wealth
  • HC orders reinstatement of ACC official Sharif, who was fired after probing high-profile corruption
  • ACC sues Saad Musa Group chief over TK95cr embezzlement
  • ACC launches probe against 2 more NBR commissioners, 3 other officials
  • NCP leaders accuse ACC of demanding bribe, commission denies claim

Features

Photo: Collected/BBC

What Hitler’s tariff policy misfire can teach the modern world

13h | The Big Picture
Illustration: TBS

Behind closed doors: Why women in Bangladesh stay in abusive marriages

16h | Panorama
Purbachl’s 144-acre Sal forest is an essential part of the area’s biodiversity. Within it, 128 species of plants and 74 species of animals — many of them endangered — have been identified. Photo: Syed Zakir Hossain/TBS

A forest saved: Inside the restoration of Purbachal's last Sal grove

16h | Panorama
Photo: Rajib Dhar/TBS

11 July 2024: Riot vehicles, water cannons hit the streets as police crack down on protesters

9h | Panorama

More Videos from TBS

'Hypocrisy' will not continue, Iran tells IAEA

'Hypocrisy' will not continue, Iran tells IAEA

12h | TBS World
OpenAI to release web browser in challenge to Google Chrome

OpenAI to release web browser in challenge to Google Chrome

12h | TBS World
Will the title 'Honorable and Excellency' be abolished?

Will the title 'Honorable and Excellency' be abolished?

13h | TBS Today
July Declaration must be constitutionally recognized: Akhtar Hossain

July Declaration must be constitutionally recognized: Akhtar Hossain

12h | TBS Today
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net